Latest Research And Development News

Visionflex Group Limited reported a net cash outflow of AUD 1.34 million for Q1 2025, maintaining liquidity through convertible note facilities that extend funding runway to over two quarters.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

BauMart Holdings Limited has announced a rights issue to raise approximately $482,000 by offering new shares at a steep discount, aiming to accelerate equipment delivery, fund R&D, and support international recruitment.

Hammer Metals Limited reported significant progress in its March 2025 quarter, highlighting promising drilling results at Lady Jenny and Mount Mascotte, alongside ongoing joint venture activities and a solid financial position.

BauMart Holdings has unveiled a multi-pronged strategy to tackle construction labour shortages, advance green building materials, and expand mining equipment services, supported by a $482,000 rights issue.

Jindalee Lithium advances its McDermitt Lithium Project in the US with a robust 63-year Pre-Feasibility Study, enhanced permitting progress, and strong US government support under the FAST-41 initiative. Strategic partnerships and funding efforts are underway to de-risk and develop this critical mineral asset.

Orbital Corporation Ltd reported a positive operating cash flow of $0.7 million for Q1 2025, supported by a solid order book and ongoing development of a new larger capacity engine prototype.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Radiopharm Theranostics has bolstered its cash position with an $8 million placement from Lantheus Holdings, now its largest shareholder. New clinical data highlight promising advances in brain metastases detection and HER2-targeted radiopharmaceutical therapies.

Streamplay Studio Limited reported a remarkable 827% increase in customer receipts for Q3 2025, driven by the full integration of Noodlecake Studios. With a robust cash balance of A$7.7 million and no debt, the company is well-positioned to accelerate growth across cloud gaming, game publishing, and emerging markets.

Critica Limited has declared a maiden Inferred Mineral Resource Estimate for its Jupiter Project, establishing it as Australia’s largest and highest-grade clay-hosted rare earth deposit. Early metallurgical testwork shows promising beneficiation results, positioning the company as a strategic player in the rare earths sector.

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.